Description
Δ8-THC analog with 13-fold selectivity for the CB2 receptor (Kis = 12.3 and 0.91 nM, for CB1 and CB2 respectively); its CB agonist activity inhibits human U87 glioma cell proliferation in vitro ( IC50 = 1.4 μM) and in vivo (2 mg/kg in a SCID mouse xenograft side-pocket model)
Formal name: 6aR,7,10,10aR-tetrahydro-6,6,9-trimethyl-3-(1-methyl-1-phenylethyl)-6H-dibenzo[b,d]pyran-1-ol
Synonyms:
Molecular weight: 362.5
CAS: 628263-22-9
Purity: ≥98%
Formulation: A crystalline solid
Product Type|Biochemicals|Receptor Pharmacology|Agonists||Research Area|Cancer||Research Area|Neuroscience|Cannabinoid Research|CB1 & CB2 Receptors